NN&I - July 2010
www.nephronline.comJuly 2010 Nephrology News & Issues 57 Index of Advertisers Genzyme, a global health care company, delivers innova- tive biotechnolo- gy products and services in thera- peutics, surgery, and diagnostic areas. Genzyme is the manufacturer of Renvela® (sevelamer carbonate), and Hectorol® (doxercalciferol capsules and injec- tion). Genzyme is a leader in health care awareness and edu- cation for health care professionals and patients worldwide. For more information visit www.genzyme.com or call medical information at 800.847.0069 Products & Services Extra Citrate chelates calcium ions and therefore inhibits coagulation, acting as an anticoagulant.CitraPureCitric-Acid Concentrate The new standard in dialysis concentrateDesigned for use with all your hemo patients \037 Priced for use with all your hemo patients \037 Available in both liquid and dry acid concentrate \037 Available in 45X, 36.83X and 35X dilution ratios \037 Call: 800-449-3353 Dialysis Products website: www.rockwellmed.com®DVA Laboratory Servicessm is a spe-cialty lab offering an extensive test menu, tools and resources to assist nephrologists in managing their patients, through- out all stages of Chronic Kidney Disease. We provide quality on-time, accurate results to help you effectively manage your renal patients. Our software application, Falcon LabTM connects the physician's office or dialysis facility with the laboratory for ultimate efficiency. This web-based system solution is user-friendly, interface capable with clinical systems and is accessible from any computer, anytime, anywhere. For addi- tional information, visit www.dvalab.com. DaVita Inc., a Fortune 500® company, is a leading provider of kidney care in the United States, delivering dialysis services and education to patients with chronic kidney failure and end stage renal disease. As of March 31, 2010, DaVita operated or provided admin- istrative services at 1,544 outpatient dialysis facilities, serving approximately 119,000 patients. DaVita develops, participates in and donates to numerous programs dedicated to transforming communities and creating positive, sustainable change for children, fami- lies and our environment. The company's leadership development initiatives and corpo- rate social responsibility efforts have been recognized by Fortune, Modern Healthcare, Newsweek and WorldBlu, among others. For more information, please visit www.davita.com. B. Braun Medical Inc. announces the Diacap Polysulfone+ HiFlo 23 dialyzer for an efficient high-flux dialysis and hemodiafiltration. The HiFlo 23 dialyzer with a Modified Polysulfone membrane is based on an advanced optimized membrane structure that allows for a highly efficient dialysis. This membrane structure is a further development of the proven polysulfone tech-nology manufactured by B. Braun in a spe-cially designed produc-tion facility. The HiFlo 23 dialyzer is Gamma sterilized. For more information, contact the Renal Therapies Division at 800-848-2066. Ads_NNI0710.indd 57 6/17/10 2:52:58 PM
You must have JavaScript enabled to view digital editions.
